Page last updated: 2024-10-30

leflunomide and Obesity

leflunomide has been researched along with Obesity in 2 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research Excerpts

ExcerptRelevanceReference
"Treatment with leflunomide or low doses of glucocorticoids were not associated with severe course in our cohort."2.82COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia. ( Hočevar, A; Ješe, R; Kramarič, J; Rotar, Ž; Tomšič, M, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kramarič, J1
Ješe, R1
Tomšič, M1
Rotar, Ž1
Hočevar, A1
Chen, J1
Sun, J1
Doscas, ME1
Ye, J1
Williamson, AJ1
Li, Y2
Prinz, RA1
Xu, X1

Reviews

1 review available for leflunomide and Obesity

ArticleYear
COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia.
    Clinical rheumatology, 2022, Volume: 41, Issue:8

    Topics: Cardiovascular Diseases; COVID-19; Giant Cell Arteritis; Glucocorticoids; Humans; Hypertension; Lefl

2022

Other Studies

1 other study available for leflunomide and Obesity

ArticleYear
Control of hyperglycemia in male mice by leflunomide: mechanisms of action.
    The Journal of endocrinology, 2018, Volume: 237, Issue:1

    Topics: 3T3-L1 Cells; Aniline Compounds; Animals; Blood Glucose; Cells, Cultured; Crotonates; Glucose; Gluco

2018